|
Friday 30th July 2021 |
Text too small? |
Further to advice provided on 3 June 2021, regarding difficulties with trading in the first half of FY22 (1H22: Feb to July 21), NZK is now able to be more specific on full year guidance.
The 2022 earnings forecast of proforma EBITDA is in the range of $8.0m to $10.0m, the majority to be generated in 2H22.
Fish size, which was a problem in the first half due to a one-off issue with the model, has now recovered and biomass is on track for a satisfactory position in October 2021. Price increases have also been implemented.
A hearing date has been established for the open ocean farming consent application, named “Blue Endeavour”, in October 2021, which has the potential to generate significant supply in future years.
Please see the link below for details
Source: New Zealand King Salmon Investments Limited
No comments yet
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update
CVT - Comvita Rights Offer Opens
GNE - FY26 Q3 Performance Report and Updated Guidance
April 23rd Morning Report
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m